全文获取类型
收费全文 | 8227篇 |
免费 | 178篇 |
国内免费 | 5篇 |
专业分类
耳鼻咽喉 | 78篇 |
儿科学 | 348篇 |
妇产科学 | 1973篇 |
基础医学 | 858篇 |
口腔科学 | 423篇 |
临床医学 | 829篇 |
内科学 | 861篇 |
皮肤病学 | 148篇 |
神经病学 | 418篇 |
特种医学 | 415篇 |
外科学 | 775篇 |
综合类 | 83篇 |
一般理论 | 1篇 |
预防医学 | 666篇 |
眼科学 | 190篇 |
药学 | 203篇 |
中国医学 | 47篇 |
肿瘤学 | 94篇 |
出版年
2018年 | 51篇 |
2017年 | 78篇 |
2015年 | 53篇 |
2014年 | 77篇 |
2013年 | 259篇 |
2012年 | 54篇 |
2011年 | 112篇 |
2010年 | 130篇 |
2009年 | 279篇 |
2008年 | 166篇 |
2007年 | 112篇 |
2006年 | 142篇 |
2005年 | 124篇 |
2004年 | 120篇 |
2003年 | 92篇 |
2002年 | 69篇 |
2001年 | 95篇 |
2000年 | 83篇 |
1999年 | 301篇 |
1998年 | 279篇 |
1997年 | 332篇 |
1996年 | 357篇 |
1995年 | 305篇 |
1994年 | 264篇 |
1993年 | 195篇 |
1992年 | 206篇 |
1991年 | 227篇 |
1990年 | 161篇 |
1989年 | 153篇 |
1988年 | 150篇 |
1987年 | 122篇 |
1986年 | 161篇 |
1985年 | 127篇 |
1984年 | 111篇 |
1983年 | 148篇 |
1982年 | 96篇 |
1981年 | 90篇 |
1980年 | 108篇 |
1979年 | 100篇 |
1978年 | 69篇 |
1977年 | 102篇 |
1976年 | 106篇 |
1975年 | 101篇 |
1974年 | 73篇 |
1973年 | 75篇 |
1972年 | 50篇 |
1971年 | 50篇 |
1970年 | 51篇 |
1923年 | 43篇 |
1922年 | 60篇 |
排序方式: 共有8410条查询结果,搜索用时 15 毫秒
131.
J. Golding Professor 《BJOG : an international journal of obstetrics and gynaecology》1998,105(3):293-299
Objective To investigate whether low dose aspirin medication given to primiparous women provides benefit in preventing pre-eclampsia or intrauterine growth retardation.
Design Randomised double-blind controlled trial of low dose aspirin and placebo in pregnancy.
Population Residents of the parishes of Kingston and St Andrew, Jamaica; 6275 primiparae enrolled between 12 and 32 weeks of gestation.
Main outcome measures Hypertensive disorders of pregnancy (including pre-eclampsia and eclampsia), preterm delivery, and low birthweight. In addition, to assess whether enrolment early, rather than late had more beneficial effect. Possible adverse effects on the woman and her infant were monitored.
Results Of enrolled primiparae, 97% were followed throughout pregnancy. There were no differences between those on aspirin and those on placebo in the development of hypertensive disorders (e.g. for a rise in diastolic pressure of 25 mmHg the odds ratio [OR] was 1.02 [95% CI 0.86–1.211; for proteinuric pre-eclampsia OR 1.15 [95% CI 0.92–1.44]; eclampsia OR 0.82 [95% CI 0.44–1.531); except for oedema which was significantly less prevalent in those on aspirin (OR 0.85 [95% CI 0.75–0.961). Women on aspirin were not significantly less likely to deliver preterm (OR 0.93 [95% CI 0–79-1.091) or have a larger fetus (mean birthweight difference 18 g [95% CI -9 to 451). They were, however, significantly more likely to suffer from bleeding disorders antenatally, intrapartum and postpartum; for postpartum haemorrhage OR 1.40 (95% CI 1.13–1-73).
Conclusions This trial shows that low dose aspirin has no consistent beneficial effect in primiparae. 相似文献
Design Randomised double-blind controlled trial of low dose aspirin and placebo in pregnancy.
Population Residents of the parishes of Kingston and St Andrew, Jamaica; 6275 primiparae enrolled between 12 and 32 weeks of gestation.
Main outcome measures Hypertensive disorders of pregnancy (including pre-eclampsia and eclampsia), preterm delivery, and low birthweight. In addition, to assess whether enrolment early, rather than late had more beneficial effect. Possible adverse effects on the woman and her infant were monitored.
Results Of enrolled primiparae, 97% were followed throughout pregnancy. There were no differences between those on aspirin and those on placebo in the development of hypertensive disorders (e.g. for a rise in diastolic pressure of 25 mmHg the odds ratio [OR] was 1.02 [95% CI 0.86–1.211; for proteinuric pre-eclampsia OR 1.15 [95% CI 0.92–1.44]; eclampsia OR 0.82 [95% CI 0.44–1.531); except for oedema which was significantly less prevalent in those on aspirin (OR 0.85 [95% CI 0.75–0.961). Women on aspirin were not significantly less likely to deliver preterm (OR 0.93 [95% CI 0–79-1.091) or have a larger fetus (mean birthweight difference 18 g [95% CI -9 to 451). They were, however, significantly more likely to suffer from bleeding disorders antenatally, intrapartum and postpartum; for postpartum haemorrhage OR 1.40 (95% CI 1.13–1-73).
Conclusions This trial shows that low dose aspirin has no consistent beneficial effect in primiparae. 相似文献
132.
S. Chua Senior Lecturer/Consultant M. Lee House Officer K. Vanaja Registrar Y. S. Chong Registrar L. Nordstrom Senior Teaching Fellow S. Arulkumaran Professor/Head 《BJOG : an international journal of obstetrics and gynaecology》1998,105(3):352-356
In order to assess the reliability of intrauterine pressure measurements in the third stage of labour, catheter-tip transducers were used in 20 women randomly allocated into two groups of 10. In each case in the first group two catheters were tied together and introduced transcervically into the uterine cavity after delivery of the placenta. In each case in the second group two catheters were inserted independently into the same uterine cavity. The active and cumulative active pressures recorded from the pairs of catheters within each uterine cavity were compared. Comparison of individual active pressure readings from separate transducers revealed good agreement whether the catheters were tied together or were seperate. Cumulative active pressure was very similar when assessed by each catheter in the same uterus. Intrauterine catheter-tip transducers can be used reliably to measure uterine activity in the third stage of labour although there may be minor contraction by contraction differences in recordings of individual active pressures. 相似文献
133.
Incidence of urinary incontinence and constipation during pregnancy and postpartum: survey of current findings at the Rotunda Lying-in Hospital 总被引:5,自引:0,他引:5
Kathleen Marshall Superintendent Physiotherapist Kate A. Thompson Research Officer † Deirdre M. Walsh Lecturer † George D. Baxter Professor † 《BJOG : an international journal of obstetrics and gynaecology》1998,105(4):400-402
Objective To assess the impact of pregnancy upon continence and constipation.
Design A questionnaire survey.
Setting Maternity wards in the Rotunda Lying In Hospital, Dublin, Republic of Ireland.
Population 7771 women who were delivered of liveborn infants.
Methods Questionnaires were delivered and collected by physiotherapy staff as part of routine postnatal care.
Results Analysis of data using χ2 tests showed significant differences between three parity groups [primigravidae, multigravidae (2–4) and multigravidae (5+)] for symptoms of both urinary incontinence ( χ2 = 119.54 , df = 2, P = 0.000) and constipation ( χ2 = 12.53 , df = 3, P = 0.002); the incidence of both constipation and urinary incontinence increased with parity.
Conclusion The results of this survey have emphasised the relation between parity and postpartum incontinence which stresses the importance of early diagnosis and intervention. 相似文献
Design A questionnaire survey.
Setting Maternity wards in the Rotunda Lying In Hospital, Dublin, Republic of Ireland.
Population 7771 women who were delivered of liveborn infants.
Methods Questionnaires were delivered and collected by physiotherapy staff as part of routine postnatal care.
Results Analysis of data using χ
Conclusion The results of this survey have emphasised the relation between parity and postpartum incontinence which stresses the importance of early diagnosis and intervention. 相似文献
134.
Linda Cardozo Professor Christopher Benness Consultant Denise Abbott Research Nurse 《BJOG : an international journal of obstetrics and gynaecology》1998,105(4):403-407
Objective To assess the efficacy of oral oestriol in the prevention of recurrent Urinary tract infections in elderly women.
Design Double-blind, randomised, parallel group, placebo controlled trial
Setting Urogynaecology Unit at King's College Hospital with some women recruited from the geriatric units of St. Pancras Hospital and Dulwich Hospital, London (UK).
Participants Seventy-two postmenopausal women older than 60 years of age (mean 73.2 years) suffering from recurrent urinary tract infections.
Intervention Oral oestriol (3 mg per day) or placebo for six months.
Main outcome measures Urinary tract infection rates.
Results The study was difficult to conduct because of its design and the age of the participants. Oral oestriol (3 mg per day) was not shown to be superior to placebo in the prevention of recurrent urinary tract infections, but both oestriol and placebo improved urinary symptoms during the trial.
Conclusion The power of the study might have been too low to detect a significant difference between the groups, or oral oestriol(3 mg per day) may have been either the wrong dose or the wrong route of administration for this indication. 相似文献
Design Double-blind, randomised, parallel group, placebo controlled trial
Setting Urogynaecology Unit at King's College Hospital with some women recruited from the geriatric units of St. Pancras Hospital and Dulwich Hospital, London (UK).
Participants Seventy-two postmenopausal women older than 60 years of age (mean 73.2 years) suffering from recurrent urinary tract infections.
Intervention Oral oestriol (3 mg per day) or placebo for six months.
Main outcome measures Urinary tract infection rates.
Results The study was difficult to conduct because of its design and the age of the participants. Oral oestriol (3 mg per day) was not shown to be superior to placebo in the prevention of recurrent urinary tract infections, but both oestriol and placebo improved urinary symptoms during the trial.
Conclusion The power of the study might have been too low to detect a significant difference between the groups, or oral oestriol(3 mg per day) may have been either the wrong dose or the wrong route of administration for this indication. 相似文献
135.
136.
Plasma from pre-eclamptic women and functional change in myometrial resistance arteries 总被引:1,自引:0,他引:1
Janet R. Ashworth Specialist Registrar Averil Y. Warren Chief Technician Ian R. Johnson Professor Philip N. Baker Senior Lecturer 《BJOG : an international journal of obstetrics and gynaecology》1998,105(4):459-461
This study assesses the ability of plasma from women with pre-eclampsia to induce altered endothelial function in myometrial resistance vessels from normotensive women. Vessels from normotensive pregnant women (n= 7) were incubated with plasma from other pregnant women who were normotensive (n= 6)or had pre-eclampsia (n= 7). A wire myograph was used to test the endothelium-dependent relaxatory response to bradykinin of preconstricted vessels. The relaxation in vessels incubated with plasma from women with pre-eclampsia was markedly less than in vessels incubated with plasma from normotensive pregnant women ( P = 0.039 ). This supports the theory that a plasma-borne factor contributes to the endothelial changes seen in pre-eclampsia. 相似文献
137.
Pekka Venesmaa Clinical Research Fellow Ulf-Håkan Stenman Consultant † Matti Forss Physicist Arto Leminen Consultant Pentti Lehtovirta Consultant Juhani Vartiainen Clinical Research Fellow Jorma Paavonen Associate Professor 《BJOG : an international journal of obstetrics and gynaecology》1998,105(5):508-511
Objective To evaluate the use of the pre-operative tumour-associated trypsin inhibitor (TATI) level and residual tumour size at primary surgery as a prognostic indicators for patients with Stage III epithelial ovarian cancer.
Design Retrospective cohort study.
Setting Department of Obstetrics and Gynaecology, University Hospital, Helsinki, Finland.
Participants Ninety-eight women with Stage III ovarian cancer.
Methods TATI was measured by radioimmunoassay from serum samples obtained within one week before surgery. A cutoff value of 22 μg/L was used. Multivariate analysis included pre-operative TATI level, age, histologic grade and histologic type. Mantel-Cox test was used for calculating statistical significance of differences in survival between groups.
Main outcome measures Cumulative five-year survival, pre-operative serum TATI level and residual tumour size.
Results Surgery was optimal (residual tumour size ≤ 2 cm) in 55 patients and suboptimal (residual tumour size > 2 cm) in 43. Pre-operative TATI level ≤ 22 μg/L predicted better prognosis both in patients with optimal and suboptimal surgery compared with patients with pre-operative TATI level > 22 μ/L. Patients with optimal surgery and a pre-operative TATI > 22 μg/L had a twofold relative risk of death compared with those with a pre-operative TATI ≤ 22 μg/L. The cumulative survival was less than three years for patients with suboptimal surgery and pre-operative TATI > 22 μg/L.
Conclusions Pre-operative serum TATI in combination with residual tumour size may be useful in stratifying patients with Stage III ovarian cancer into different categories in randomised treatment trials. 相似文献
Design Retrospective cohort study.
Setting Department of Obstetrics and Gynaecology, University Hospital, Helsinki, Finland.
Participants Ninety-eight women with Stage III ovarian cancer.
Methods TATI was measured by radioimmunoassay from serum samples obtained within one week before surgery. A cutoff value of 22 μg/L was used. Multivariate analysis included pre-operative TATI level, age, histologic grade and histologic type. Mantel-Cox test was used for calculating statistical significance of differences in survival between groups.
Main outcome measures Cumulative five-year survival, pre-operative serum TATI level and residual tumour size.
Results Surgery was optimal (residual tumour size ≤ 2 cm) in 55 patients and suboptimal (residual tumour size > 2 cm) in 43. Pre-operative TATI level ≤ 22 μg/L predicted better prognosis both in patients with optimal and suboptimal surgery compared with patients with pre-operative TATI level > 22 μ/L. Patients with optimal surgery and a pre-operative TATI > 22 μg/L had a twofold relative risk of death compared with those with a pre-operative TATI ≤ 22 μg/L. The cumulative survival was less than three years for patients with suboptimal surgery and pre-operative TATI > 22 μg/L.
Conclusions Pre-operative serum TATI in combination with residual tumour size may be useful in stratifying patients with Stage III ovarian cancer into different categories in randomised treatment trials. 相似文献
138.
Uterine thermal balloon therapy for the treatment of menorrhagia: the first 300 patients from a multi-centre study 总被引:6,自引:0,他引:6
Nazar N. Amso Consultant Seth A. Stabinsky Clinical Assistant Professor/Associate Medical Director †‡ Peter McFaul Consultant Bernard Blanc Professor †† Laura Pendley Manager ‡ Robert Neuwirth Professor/Chairman Emeritus § 《BJOG : an international journal of obstetrics and gynaecology》1998,105(5):517-523
139.
Changes in the expression of the type-2 but not the type-1 cyclo-oxygenase enzyme in chorion-decidua with the onset of labour 总被引:3,自引:0,他引:3
Donna Slater Senior Research Fellow Victoria Allport Research Assistant Phillip Bennett Professor 《BJOG : an international journal of obstetrics and gynaecology》1998,105(7):745-748
Objective To determine the relative expression of cyclo-oxygenase (COX)-1 and COX-2 in the chorion-decidual part of human fetal membranes following delivery at term and to identify any changes in expression associated with labour.
Methods Fetal membranes were collected from 12 term pregnancies before labour following elective caesarean section and from 12 spontaneous vaginal deliveries. Expression of COX-1 and COX-2 mRNA was measured using a previously validated quantitative RT-PCR assay.
Results COX-2 expression exceeded that of COX-1 by approximately eight-fold. COX1 expression did not change but COX-2 expression was found to increase four-fold with labour.
Conclusions Chorion-decidua has the capacity to contribute to the increase in prostaglandin synthesis within the uterus associated with labour. As in the amnion, it is COX-2 and not COX-1 which is upregulated with labour. COX-2 selective anti-prostaglandins should therefore be as effective as nonselective drugs in inhibition of fetal membrane prostaglandin synthesis. 相似文献
Methods Fetal membranes were collected from 12 term pregnancies before labour following elective caesarean section and from 12 spontaneous vaginal deliveries. Expression of COX-1 and COX-2 mRNA was measured using a previously validated quantitative RT-PCR assay.
Results COX-2 expression exceeded that of COX-1 by approximately eight-fold. COX1 expression did not change but COX-2 expression was found to increase four-fold with labour.
Conclusions Chorion-decidua has the capacity to contribute to the increase in prostaglandin synthesis within the uterus associated with labour. As in the amnion, it is COX-2 and not COX-1 which is upregulated with labour. COX-2 selective anti-prostaglandins should therefore be as effective as nonselective drugs in inhibition of fetal membrane prostaglandin synthesis. 相似文献
140.